Back to Search
NICHOLAS SABA, MD
MD
Ophthalmology Physician
NPI: 1528689387IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
35.150110(OH)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
OTHER
Class of 2020
Research & Publications (20)
Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.
PMID 19072997·Head Neck·2009
8-other
Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis.
PMID 19431199·Head Neck·2009
8-other
Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents.
PMID 19370807·Curr Opin Oncol·2009
6-review
Global health in Canadian medical education: current practices and opportunities.
PMID 18303368·Acad Med·2008
8-other
Beyond borders: building global health programs at McGill University Faculty of Medicine.
PMID 18303367·Acad Med·2008
8-other
Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
PMID 18473353·Cancer·2008
8-other
Moving toward bioadjuvant approaches to head and neck cancer prevention.
PMID 17848282·Int J Radiat Oncol Biol Phys·2007
6-review
Targeting the epidermal growth factor receptor. Trials in head and neck and lung cancer.
PMID 16562649·Oncology (Williston Park)·2006
6-review
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
PMID 15775688·Oncology·2005
6-review
Technology evaluation: mapatumumab, Human Genome Sciences/GlaxoSmithKline/Takeda.
PMID 16248286·Curr Opin Mol Ther·2005
6-review
Chemoprevention strategies for patients with lung cancer in the context of screening.
PMID 16179095·Clin Lung Cancer·2005
6-review
Retinoids as chemoprevention for head and neck cancer: where do we go from here?
PMID 15886010·Crit Rev Oncol Hematol·2005
6-review
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 2: Clinical studies and economic analyses.
PMID 15775689·Oncology·2005
6-review
On the current incidence of deformational plagiocephaly: an estimation based on prospective registration at a single center.
PMID 15828714·Semin Pediatr Neurol·2004
4-observational
Novel targeted agents in the treatment of lung cancer.
PMID 15174948·Expert Opin Investig Drugs·2004
6-review
Molecular biological design of novel antineoplastic therapies.
PMID 15174947·Expert Opin Investig Drugs·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 915 OLENTANGY RIVER RD FL 5
COLUMBUS, OH 43212 - Phone
- (614) 293-8116
Quick Facts
- NPI
- 1528689387
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile